Evidence map›Paper›PMID 22058021›Full record

ReviewImmunologic research2011

Mechanisms controlling granule-mediated cytolytic activity of cytotoxic T lymphocytes.

Nadia Anikeeva, Yuri Sykulev

Open access · greenAbstract readReview
In one paragraph

Review in Immunologic research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Factors contributing to the potency of CD8Trends in immunology · 2023
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Aurora A controls CD8Scientific reports · 2019
    Article
  9. Article
  10. Article
  11. T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Laboratory investigation; a journal of technical methods and pathology · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cytotoxic immunological synapses do not restrict the action of interferon-γ to antigenic target cells.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Nadia AnikeevaDepartment of Microbiology and Immunology, Kimmel Cancer Center and Jefferson Vaccine Center, Thomas Jefferson University, Philadelphia, PA 19107, USA. nanikeye@mail.jci.tju.edu
Yuri Sykulev
Sidney Kimmel Cancer Center · USThomas Jefferson University · US

Funding

Immune receptors on Cytotoxic Lymphocytes&Target CellR01AI052812 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SYKULEV, YURI · 2002 to 2012
$3.5M
Immune Receptors on Cytotoxic Lymphocytes and Target CellsR56AI052812 · NIAID · THOMAS JEFFERSON UNIVERSITY · PI SYKULEV, YURI · 2007 to 2007
$412k
Proximity between immune receptors on the cell surface and the sensitivity of TceR21CA131973 · NCI · THOMAS JEFFERSON UNIVERSITY · PI SYKULEV, YURI · 2009 to 2010
$333k
NCI NIH HHS CA131973NCI NIH HHS R21 CA131973NIAID NIH HHS AI52812NIAID NIH HHS R01 AI052812NIAID NIH HHS R56 AI052812
6 · The paper itself

Abstract

Cytotoxic T lymphocytes (CTL) play a critical role in immunity against viruses and cancer. The antigen receptor or T-cell receptor (TCR) on CTL determines the specificity toward target cells. The CD8 co-receptor functions in concert with the TCR to enhance TCR-mediated signaling, accounting for the remarkable sensitivity and swift signaling kinetics of the CTL response. The latter ensures efficient delivery and release of lytic granules, resulting in sensitive and rapid destruction of target cells.

Indexed as

Cytotoxicity, ImmunologicAnimalsCD8 AntigensCytoplasmic GranulesHumansReceptors, Antigen, T-CellSignal TransductionT-Lymphocytes, CytotoxicCD8 AntigensReceptors, Antigen, T-Cell

Identifiers

PMID22058021
PMCPMC3244531
OpenAlexW2089544888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.